The demographic NB Registry 2016 serves as a superordinate database to enable: a standardised diagnosis, a central reference assessment of tumour samples, bone marrow and imaging to assess the spread of the tumour (staging), a standardised molecular baseline analysis, the collection of biomaterials, the correlation of molecular and clinical data, a long-term follow-up, the allocation of patients to early clinical trials, international cooperation
